A modification of the standard intraperitoneal paclitaxel/cisplatin chemotherapy regimen results in higher completion rates

被引：0
|
作者：
Lesnock, J. [1 ]
Richard, S. D. [1 ]
McBee, W. C. [1 ]
Zom, K. K. [1 ]
Sukumvanich, P. [1 ]
Edwards, R. P. [1 ]
Krivak, T. C. [1 ]
机构：
[1] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Magee Womens Hosp, Pittsburgh, PA USA
来源：
GYNECOLOGIC ONCOLOGY | 2009年 / 112卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
108
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [31] Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimen
    Gjafa, Ernese.
    Ng, Kenrick
    Grunewald, Tami
    Galazi, Myria
    Skyllberg, Erik
    Wilson, Peter
    Alifrangis, Constantine
    Shamash, Jonathan
    BJU INTERNATIONAL, 2021, 127 (02) : 205 - 211
  • [32] Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer
    Barlin, Joyce N.
    Dao, Fanny
    Zgheib, Nadim Bou
    Ferguson, Sarah E.
    Sabbatini, Paul J.
    Hensley, Martee L.
    Bell-McGuinn, Katherine M.
    Konner, Jason
    Tew, William P.
    Aghajanian, Carol
    Chi, Dennis S.
    GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 621 - 624
  • [33] Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S-1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancer
    Shinkai, Masayuki
    Imano, Motohiro
    Chiba, Yasutaka
    Iwama, Mitsuru
    Shiraisi, Osamu
    Yasuda, Atsushi
    Tsubaki, Masanobu
    Nishida, Shozo
    Kimura, Yutaka
    Yasuda, Takushi
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 119 (01) : 56 - 63
  • [34] Occupational safety of doxorubicin, cisplatin, paclitaxel, and cremophor-free polymeric micelle formulated paclitaxel during rotational intraperitoneal pressurized aerosol chemotherapy
    Park, Soo Jin
    Kim, Hee Seung
    Kim, Jae-Weon
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S216 - S216
  • [35] Comparison of outcomes with utilization of hyperthermic intraperitoneal chemotherapy with paclitaxel and cisplatin versus cisplatin alone at interval debulking surgery in women with epithelial ovarian cancer
    Horowitz, M. P.
    Chambers, L. Moulton
    Gruner, M.
    Costales, A. B.
    Morton, M.
    Chichura, A. M.
    Rose, P. G.
    Michener, C. M.
    DeBernardo, R.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 54 - 54
  • [36] New paclitaxel-cisplatin based chemotherapy regimen for advanced stage, recurrent, or refractory neuroblastoma - Preliminary report
    Surico, G
    Muggeo, P
    De Leonardis, F
    Rigillo, N
    MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 40 (02): : 130 - 132
  • [37] Results of all-intraperitoneal carboplatin and paclitaxel regimen shows good tolerability and efficacy for advanced ovarian cancer
    Krasner, C. N.
    Seiden, M. V.
    Fuller, A. F., Jr.
    Supko, J. G.
    Roche, M.
    Kendall, D. L.
    Lee, J.
    Berkowitz, R.
    Berlin, S.
    Matulonis, U. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer
    L Ansaloni
    F Coccolini
    L Morosi
    A Ballerini
    M Ceresoli
    G Grosso
    P Bertoli
    L M Busci
    M Lotti
    F Cambria
    M Pisano
    D Rossetti
    L Frigerio
    M D'Incalci
    M Zucchetti
    British Journal of Cancer, 2015, 112 : 306 - 312
  • [39] Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer
    Ansaloni, L.
    Coccolini, F.
    Morosi, L.
    Ballerini, A.
    Ceresoli, M.
    Grosso, G.
    Bertoli, P.
    Busci, L. M.
    Lotti, M.
    Cambria, F.
    Pisano, M.
    Rossetti, D.
    Frigerio, L.
    D'Incalci, M.
    Zucchetti, M.
    BRITISH JOURNAL OF CANCER, 2015, 112 (02) : 306 - 312
  • [40] Feasibility and toxicity of intraperitoneal cisplatin-paclitaxel chemotherapy (IPC) for epithelial ovarian cancer (EOC) in a routine clinical setting
    Braun, S.
    Zeimet, A. G.
    Hefler, L.
    Weissenboeck, E.
    Kickmaier, S.
    Volgger, B.
    Reinthaller, A.
    Marth, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345